Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- Key things to know ahead of SK Hynix’s blockbuster US listing
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
Goldman Sachs Comments on Clarivate Plc (CLVT) Earnings
May 8, 2024 7:34 AM EDTGoldman Sachs analyst George K. Tong reiterated a Buy rating and $8.50 price target on Clarivate Plc (NYSE: CLVT).
The analyst comments "We expect investors to have a neutral-to-positive reaction to Clarivates 1Q 2024 earnings release, with revenue and EBITDA outperforming consensus (FactSet) expectations and the full year guide reaffirmed. Organic... More
